Plasmalogens Supplements and Their Connection to Alzheimer's Disease
The development of mass spectrometry-based techniques has made it possible to compare the molecules that are changed during Alzheimer's disease. A constant decrease of plasmalogens is one of the modifications shown by this research. The varieties of phospholipids present in membranes are extremely diverse, and plasmalogens constitute a component of that vast terrain. Plasmalogens account for more than 20% of all phospholipids in humans, and they are especially abundant in the nervous system. Plasmalogen levels drop by up to 40% in Alzheimer's patients. The discovery of this large decrease in plasmalogens is critical in two areas of Alzheimer's disease: early detection and therapeutic intervention. First, these plasmalogen reductions might be effective indicators for detecting the development of Alzheimer's disease. Detecting plasmalogens levels has the benefit over other detection methods in that lower plasmalogens may be observed in blood and do not require costly an